
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CASE REPORT article
Front. Med.
Sec. Nephrology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1506592
This article is part of the Research Topic Disparities in Nephrotic Syndrome Outcomes View all 3 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The association of renal cell carcinoma (RCC) with paraneoplastic membranous nephropathy (MN) is rare. Accurate identification and treatment of the primary tumor can lead to resolution of nephrotic syndrome.We report the case of a 72-year-old male was referred to Nephrology due to significant proteinuria (Urine albumin-creatinine ratio 14000 mg/g) without clinical nephrotic syndrome. Imaging revealed a nodular lesion in the left kidney, compatible with the diagnosis of papillary renal neoplasia. A total left nephrectomy confirmed papillary RCC and MN. Post-surgery, renal function initially declined but stabilized, with proteinuria significantly reduced by the latest follow-up.Review of 20 cases of nephrotic syndrome associated with RCC revealed that MN was the most frequent underlying nephrosis. MN is frequently associated with solid tumors, but its link with RCC is uncommon. In our review, clear cell carcinoma (CCC) was the most prevalent RCC subtype linked with MN. Early cancer screening in MN patients can uncover occult malignancies, facilitating timely treatment. RCC-associated MN is rare but should be considered in patients presenting with nephrotic syndrome. Surgical resection of the RCC can lead to resolution of the associated nephropathy. This case underscores the importance of thorough cancer screening in patients with unexplained nephrotic syndrome.
Keywords: Membranous nephropathy, Nephrotic Syndrome, Papillary renal cell carcinoma, Nephrectomy, paraneoplastic nephropathy, case report
Received: 05 Oct 2024; Accepted: 11 Mar 2025.
Copyright: © 2025 Singh Singh, Naranjo, Alonso, Villanego, Amaro, Carrasco, Salvatierra and Mazuecos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Arshdeep Singh Singh, Hospital Universitario Puerta del Mar, Cadiz, Spain
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.